• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.20% Nasdaq Up0.41%

    Becton, Dickinson and Company (BDX)

    137.76 Up 0.64(0.47%) Oct 9, 4:01PM EDT
    |After Hours : 137.76 0.00 (0.00%) Oct 9, 4:38PM EDT
    ProfileGet Profile for:
    Becton, Dickinson and Company
    1 Becton Drive
    Franklin Lakes, NJ 07417
    United States - Map
    Phone: 201-847-6800
    Website: http://www.bd.com

    Index Membership:N/A
    Industry:Medical Instruments & Supplies
    Full Time Employees:30,619

    Business Summary 

    Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company’s BD Medical segment produces medical devices, such as needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for use in the treatment of diabetes; prefillable drug delivery systems; anesthesia needles and trays; sharps disposal containers; and closed-system transfer devices. Its BD Life Sciences segment provides products for the collection and transportation of diagnostics specimens; and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections, and cancers. This segment’s products include integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood and tuberculosis culturing systems; molecular testing systems; microorganism identification and drug susceptibility systems; liquid-based cytology systems; rapid diagnostic assays; microbiology laboratory automation; and plated media. It also offers research and clinical tools, such as fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing. In addition, the company develops technologies that address biological analysis protocols, including library preparation of next generation sequencing and genotyping applications. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. It has a collaboration with Seegene, Inc. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

    Key Statistics

    Company Websites 
    Home Page
    Investor Relations
    Search Yahoo! for:
    More on Becton, Dickinson and Company

    Corporate Governance 
    Becton, Dickinson and Company’s ISS Governance QuickScore as of Oct 1, 2015 is 3. The pillar scores are Audit: 2; Board: 4; Shareholder Rights: 6; Compensation: 2.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. Vincent A. Forlenza , 62
    Chairman, Chief Exec. Officer, Pres and Chairman of Exec. Committee
    Mr. Christopher R. Reidy , 58
    Chief Financial Officer and Exec. VP of Admin.
    Mr. William A. Kozy , 63
    Chief Operating Officer and Exec. VP
    Mr. Jeffrey S. Sherman Esq., 60
    Exec. VP and Gen. Counsel
    Dr. Ellen R. Strahlman M.D., M.H.Sc., 58
    Chief Medical Officer and Exec. VP of R&D
    Mr. John E. Gallagher , 42
    VP of Corp. Fin., Treasurer and Controller
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders